M
Michael S. Kent
Researcher at University of California, Davis
Publications - 270
Citations - 7358
Michael S. Kent is an academic researcher from University of California, Davis. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 44, co-authored 248 publications receiving 6318 citations. Previous affiliations of Michael S. Kent include Hebrew University of Jerusalem & University Hospital Southampton NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus
TL;DR: Esophagectomy with three-field lymph node dissection can be performed with a low mortality and reasonable morbidity, and an overall 5-year survival rate of 51% suggests a true survival benefit beyond that achieved solely on the basis of stage migration.
Journal ArticleDOI
Open, video-assisted thoracic surgery, and robotic lobectomy: review of a national database.
Michael S. Kent,Thomas J. Wang,Richard I. Whyte,Thomas Curran,Raja M. Flores,Sidhu P. Gangadharan +5 more
TL;DR: Case volume for robotic pulmonary resection has increased significantly during the study period, and thoracic surgeons have been able to adopt the robotic approach safely, and robotic resection appears to be an appropriate alternative to VATS and is associated with improved outcomes compared with open thoracotomy.
Journal ArticleDOI
Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder.
Evanguelos Xylinas,Michael S. Kent,Luis A. Kluth,Luis A. Kluth,Armin Pycha,Evi Comploj,Robert S. Svatek,Yair Lotan,Quoc-Dien Trinh,Pierre I. Karakiewicz,Sten Holmäng,Douglas S. Scherr,Marc Zerbib,Andrew J. Vickers,S.F. Shariat,S.F. Shariat +15 more
TL;DR: The EORTC risk tables and the CUETO scoring system exhibit a poor discrimination for both disease recurrence and progression in NMIBC patients, which underline the need for improving the current predictive tools.
Journal ArticleDOI
Long-term outcome after resection for bronchial carcinoid tumors
Mark K. Ferguson,Rodney J. Landreneau,Stephen R. Hazelrigg,Nasser K. Altorki,Keith S. Naunheim,Joseph B. Zwischenberger,Michael S. Kent,Anthony P.C. Yim +7 more
TL;DR: Either major lung resection or wedge resection is appropriate treatment for patients with early stage typical bronchial carcinoid tumors regardless of histological subtype, suggesting that a formal resection may improve long-term outcome.
Journal ArticleDOI
Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells
Danielle D. Carrade,Michael W. Lamé,Michael S. Kent,Kaitlin C. Clark,Naomi J. Walker,Dori L. Borjesson +5 more
TL;DR: Activated equine MSCs derived from BM, AT, CT, and CB secrete high concentration of mediators and are similar to M SCs from rodents and humans in their immunomodulatory profiles, which have implication for the treatment of inflammatory lesions dominated by activated lymphocytes and TNF-α and IFN-γ in vivo.